ACAD
ACAD
NASDAQ · Biotechnology

Acadia Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$28.75
-0.05 (-0.17%)
Analyst Consensus
Strong Buy
27
Analysts
High
Coverage
Buy 21 78%
Hold 5 19%
Sell 1 4%
Price Target
Analyst Price Target -37.7% upside
Low Target $12.70
Average Target $17.90
High Target $23.84
Current Price $28.75
Current
$28.75
Target
$17.90
$12.70 $17.90 avg $23.84
Scenario Analysis
Bear Case
$12.70
-55.8%
Low target
Base Case
$17.90
-37.7%
Avg target
Bull Case
$23.84
+-17.1%
High target
Risk/Reward
0.3x
Unfavorable
Price in Context
52-Week High
$28.35
1.4% from high
52-Week Low
$19.69
+46.0% from low
50-Day SMA
$25.91
+11.0% vs SMA
200-Day SMA
$23.44
+22.7% vs SMA
RSI (14)
42.4
Neutral
Target vs 52W High
$17.90
-36.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 79% $257.58 +5.4%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -52.7%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +179.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -9.5%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -90.0%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -42.1%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -46.0%
BIIB
Biogen Inc
 Buy 44 64% $91.45 -55.7%